DIGITAL PILL
LIVE

Serial Number

98313402

Owner

Inner Cosmos Inc.

Attorney

Mark I. Koffsky

Filing Date

Dec 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DIGITAL PILL Trademark

Serial Number: 98313402

DIGITAL PILL is a trademark filed by Inner Cosmos Inc. on December 13, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Inner Cosmos Inc. (5 trademarks)

1800 Green Hills Rd., Suite 105A
Scotts Valley, CA 95066

Entity Type: 03

Trademark Details

Filing Date

December 13, 2023

Registration Date

Not Registered

Goods & Services

Medical care; Provision of medical services by health care professionals via the internet or telecommunication networks; Remote monitoring of medical data for medical diagnosis and treatment; Providing medical information in the fields of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave stimulation, and brain-computer interface; Medical diagnostic testing, monitoring and reporting services using artificial intelligence; Medical treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Surgical implantation of subcutaneous microchips into humans; Medical services for treatment of neuropsychiatric disorders, including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits

Implants consisting of artificial materials; Wearable monitors used to measure biometric data for medical use; Medical devices for use in treating or diagnosing neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, with integrated recorded operating system software, sold as a unit; Surgical and medical apparatus and instruments, namely, electrocorticographic stimulation apparatus for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Non-invasive electronic neuromodulator device for medical use, namely, for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, all using artificial intelligence; Surgical and medical apparatus and instruments, namely, electrotherapy stimulation apparatus comprising electrodes for the stimulation of nerves and brain tissue using an electric field, for medical purposes; Electrocorticographic stimulation devices for physical therapy and medical therapy purposes

Medical research; Medical and scientific research in the field of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave sensing and stimulation, brain/computer interface, all using artificial intelligence; Compiling data for research purposes in the field of medical science and medical consultancy; Providing temporary use of non-downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence

Downloadable software as a Medical Device (SaMD) for treating neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Downloadable computer software for controlling and managing patient medical information; Downloadable medical software as a medical device (SaMD) for treatment of neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Computer hardware and recorded software sold as a unit for use with electrocorticographic stimulation devices, for receiving, processing, transmitting and displaying data; Interfaces for computers, namely a device providing wireless power to implants allowing patients to interface with computer hardware sharing brain activity; Wearable computer peripherals in the form of a device providing wireless power to implants; Downloadable software for connecting, operating, and managing networked hardware devices, namely, implants, a device providing wireless power to implants, computer hardware, phones, laptops, desktops, tablets, smartwatches, smartrings, headsets wearable devices in the internet of things (IoT); Microcontrollers for internet of things (IoT) enabled devices; Downloadable computer software for operating therapeutic, diagnostic and rehabilitation medical systems, namely, computer software to measure biometric data for diagnosing and treating neuropsychiatric disorders, namely depression, anxiety disorders, OCD, substance use disorders, PTSD, addiction, cognitive disorders, sensorimotor deficits; Downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 13, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 22, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 21, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 21, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 21, 2024 GNSL
SUSPENSION LETTER WRITTEN
Oct 21, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 12, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2024 NWOS
NEW APPLICATION ENTERED
Dec 13, 2023 NWAP